News

The AHA, American Medical Association and American Nurses Association released a joint statement as the number of U.S. deaths related to COVID-19 approached 500,000.

Join me on this episode of Leadership Rounds with Consuelo Wilkins, M.D., vice president of health equity at Vanderbilt University Medical Center, based in Nashville.

New data from Pfizer Inc. indicates that its COVID-19 vaccine is more stable than previously believed when stored -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators.

The FBI has issued recommendations to help prevent and respond to Telephony Denial of Service (TDoS) attacks, which can make 911 call centers unavailable to users and undermine public trust in emergency services.

President Biden nominated Chiquita Brooks-LaSure to lead the Centers for Medicare & Medicaid Services. Brooks-LaSure previously served as deputy director for policy at the Center for Consumer Information and Insurance Oversight within CMS and earlier at the Department of Health and Human Services as director of coverage policy.

To help combat burnout and fatigue amidst the COVID-19 pandemic’s effects on health care workers’ wellbeing, the International Hospital Federation and the International Society for Quality in Health Care are hosting a Feb. 23 conference that will share good practices and innovations on how hospitals around the globe are improving their health care workers’ wellbeing and successful programs from other fields.

President Biden told a group of G-7 leaders that the U.S. will support the COVAX alliance tasked with distributing COVID-19 vaccines to 92 low- and middle-income countries.

The Centers for Medicare & Medicaid Services has identified Healthcare Common Procedure Coding System codes for billing Medicare for the combination monoclonal antibodies bamlanivimab and etesevimab, made by Eli Lilly and Co.

The AHA recently launched a new webpage dedicated to disseminating accessible information focused on addressing the equity issues in COVID-19 testing, treatment and vaccine administration efforts.

Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported.